RN7SL607P

Across TCGA pan-cancer cohorts, RN7SL607P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RN7SL607P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RN7SL607P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL607P expression acts as an unfavorable survival marker, although some lineages such as HNSC and GBM show a favorable association.

OV, LUSC, and ACC are the cancer types where RN7SL607P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.678	0.851	<.001	96	view →
LUSC	OS	Tertile	III,IV	0.083	0.699	<.001	90	view →
ACC	OS	Tertile	All	0.115	0.729	<.001	90	view →
THCA	OS	Tertile	II,III,IV	0.871	0.984	<.001	60	view →
THYM	DFS	Tertile	II,III,IV	0.401	0.820	<.001	57	view →
KIRC	OS	Tertile	All	0.449	0.667	.001	41	view →
BRCA	OS	Tertile	All	0.832	0.928	.006	36	view →
HNSC	DFS	Tertile	III,IV	0.797	0.642	.023	24	view →
GBM	OS	Tertile	All	0.713	0.287	.015	18	view →
LGG	OS	Tertile	All	0.573	0.816	.014	18	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	15	view →
BLCA	OS	Tertile	All	0.668	0.396	.028	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RN7SL607P–OV (OS)

Open the OV breakdown →